Mutations in NPC1L1 and coronary heart disease

New England Journal of Medicine

Volumn 372, Issue 9, 2015, Pages 881-883

  Mirshahi, Uyenlinh L ^a   Carey, David J ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN;

CHOLESTEROL BLOOD LEVEL; GENE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; MUTATIONAL ANALYSIS; NPC1L1 GENE; PHENOTYPE; PRIORITY JOURNAL; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GENE SILENCING; GENETICS; MALE; MUTATION;

CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENE SILENCING; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION;

EID: 84923826207     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1500124     Document Type: Letter

References (1)

1. The Myocardial Infarction Genetics Consortium Investigators. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med 2014;371:2072-82.